Lisa Evers

4.9k total citations
17 papers, 388 citations indexed

About

Lisa Evers is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Lisa Evers has authored 17 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Lisa Evers's work include Cancer Genomics and Diagnostics (12 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Renal cell carcinoma treatment (4 papers). Lisa Evers is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Renal cell carcinoma treatment (4 papers). Lisa Evers collaborates with scholars based in United States, United Kingdom and Switzerland. Lisa Evers's co-authors include Elizabeth Lenkiewicz, Michael T. Barrett, Tara Holley, Daniel D. Von Hoff, Christian Ruiz, Lukas Bubendorf, John D. Carpten, Jeffrey Kiefer, Ramesh K. Ramanathan and Michael J. Demeure and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Lisa Evers

17 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Evers United States 9 201 166 149 95 69 17 388
Magnus Zethoven Australia 14 145 0.7× 192 1.2× 213 1.4× 111 1.2× 53 0.8× 21 501
Sumi Yun South Korea 12 150 0.7× 215 1.3× 190 1.3× 119 1.3× 67 1.0× 25 469
Antonios Papanicolau‐Sengos United States 12 165 0.8× 275 1.7× 237 1.6× 149 1.6× 31 0.4× 36 563
Chengdu Sun China 9 178 0.9× 317 1.9× 218 1.5× 224 2.4× 29 0.4× 9 575
Ulrike Weyer-Czernilofsky Austria 11 176 0.9× 317 1.9× 344 2.3× 79 0.8× 32 0.5× 17 631
María Quindós Spain 9 180 0.9× 166 1.0× 196 1.3× 76 0.8× 64 0.9× 22 453
Emily Pittman United States 9 96 0.5× 285 1.7× 205 1.4× 126 1.3× 37 0.5× 22 508
Sameer A. Greenall Australia 13 91 0.5× 142 0.9× 203 1.4× 72 0.8× 125 1.8× 22 424
Kaltin Ferguson Australia 13 168 0.8× 229 1.4× 276 1.9× 71 0.7× 17 0.2× 21 559

Countries citing papers authored by Lisa Evers

Since Specialization
Citations

This map shows the geographic impact of Lisa Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Evers more than expected).

Fields of papers citing papers by Lisa Evers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Evers. The network helps show where Lisa Evers may publish in the future.

Co-authorship network of co-authors of Lisa Evers

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Evers. A scholar is included among the top collaborators of Lisa Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Evers. Lisa Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dreyer, Stephan B., Nigel B. Jamieson, Lisa Evers, et al.. (2019). Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling. Chinese Clinical Oncology. 8(2). 16–16. 23 indexed citations
2.
Evers, Lisa, et al.. (2018). Bromelain content of extract from stem of pineapple (Ananas comosus (L.) Merr). AIP conference proceedings. 2019. 20014–20014. 5 indexed citations
3.
Dreyer, Stephan B., Nigel B. Jamieson, Lisa Evers, et al.. (2018). Feasibility and clinical utility of EUS guided biopsy of pancreatic cancer for next-generation genomic sequencing.. Journal of Clinical Oncology. 36(4_suppl). 296–296. 1 indexed citations
4.
Cooke, Susanna L., Darren Ennis, Lisa Evers, et al.. (2017). The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma. Clinical Cancer Research. 23(24). 7633–7640. 29 indexed citations
5.
Barrett, Michael T., Elizabeth Lenkiewicz, Tara Holley, et al.. (2017). Clinical study of genomic drivers in pancreatic ductal adenocarcinoma. British Journal of Cancer. 117(4). 572–582. 33 indexed citations
6.
Cherba, David, et al.. (2014). Mesenchymal‐like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial‐like counterparts. Molecular Oncology. 8(7). 1253–1265. 6 indexed citations
7.
Egan, Jan B., Michael T. Barrett, Mia D. Champion, et al.. (2014). Whole Genome Analyses of a Well-Differentiated Liposarcoma Reveals Novel SYT1 and DDR2 Rearrangements. PLoS ONE. 9(2). e87113–e87113. 15 indexed citations
8.
Asatryan, Zareh, et al.. (2014). Der Einfluss der öffentlichen Verwaltung auf die ökonomische Performance von Ländern. IG. 37(4). 371–383. 1 indexed citations
9.
Evers, Lisa, Pedro A. Pérez–Mancera, Elizabeth Lenkiewicz, et al.. (2014). STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma. Genome Medicine. 6(1). 9–9. 24 indexed citations
10.
Stieber, Daniel, Anna Golebiewska, Lisa Evers, et al.. (2013). Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes. Acta Neuropathologica. 127(2). 203–219. 81 indexed citations
11.
Barrett, Michael T., Elizabeth Lenkiewicz, Lisa Evers, et al.. (2013). Clonal Evolution and Therapeutic Resistance in Solid Tumors. Frontiers in Pharmacology. 4. 2–2. 20 indexed citations
12.
Kurywchak, Paul, Jeffrey Kiefer, Elizabeth Lenkiewicz, et al.. (2013). Elucidating potentially significant genomic regions involved in the initiation and progression of undifferentiated pleomorphic sarcoma. Rare Tumors. 5(1). 54–59. 5 indexed citations
13.
Spengel, Christoph, et al.. (2013). Probleme einer Vermögensteuer in Deutschland: Eine ökonomische Analyse. Vierteljahrshefte zur Wirtschaftsforschung. 82(1). 129–146. 4 indexed citations
14.
Holley, Tara, Elizabeth Lenkiewicz, Lisa Evers, et al.. (2012). Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples. PLoS ONE. 7(11). e50586–e50586. 38 indexed citations
15.
Liu, Stephen V., Elizabeth Lenkiewicz, Lisa Evers, et al.. (2012). Genomic analysis and selected molecular pathways in rare cancers. Physical Biology. 9(6). 65004–65004. 7 indexed citations
16.
Barrett, Michael T., Elizabeth Lenkiewicz, Lisa Evers, et al.. (2012). Abstract 3697: Phase II study of therapy selected by molecular profiling in patients with previously treated metastatic pancreatic cancer - SU2C-001. Cancer Research. 72(8_Supplement). 3697–3697. 6 indexed citations
17.
Ruiz, Christian, Elizabeth Lenkiewicz, Lisa Evers, et al.. (2011). Advancing a clinically relevant perspective of the clonal nature of cancer. Proceedings of the National Academy of Sciences. 108(29). 12054–12059. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026